drugset
drugset / Trial / NCT03714620

Sub-dissociative Dose Ketamine Dosing Study

NCT03714620 ↗

Phase 4 Completed 98 enrolled Loyola University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Goal is to determine if in adults presenting to the Emergency Department (ED) with moderate to severe acute pain, Ketamine administered at 0.15 mg/kg will provide similar pain relief to Ketamine administered at 0.3 mg/kg, with fewer adverse effects.

Timeline

Start
2018-10-15
Primary completion
2019-09-17
Completion
2019-09-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.15 mg/kg Intravenous
Comparator Ketamine Small molecule 0.3 mg/kg Intravenous

Indications

No indication recorded.